Literature DB >> 26184358

A trimodality approach in the management of metastatic low-grade epithelioid hemangioendothelioma of the bone.

Abhijit Saste1, Diego Felipe Cabrera Fernandez2, Rohit Gulati3, Steven Gamalski1.   

Abstract

A 29-year-old man presented with a 2-week history of severe pain in the left foot with no preceding history of trauma. A left foot radiograph demonstrated a cortical lucency in the mid-distal shaft of the third metatarsal bone. MRI of the left foot showed an expansile lesion in the same location. A staging bone scan showed a focal uptake in the known lucency in the left third metatarsal and in the proximal left femur. A subsequent left hip radiograph demonstrated a lucency in the intertrochanteric region. CT scan of the chest, abdomen and pelvis was unremarkable. A biopsy of the left third metatarsal expansile lesion performed during an incision and curettage procedure revealed an epithelioid haemangioma (EHE) of the bone. MRI of the left hip performed in response to the findings on the bone scan showed metastatic disease in the left intertrochanteric region. A prophylactic left hip fixation surgery with an interlocking intramedullary femoral nail was therefore undertaken to avoid a pathological fracture of the left hip from the metastatic disease. Simultaneously, a left hip biopsy was performed, which also revealed an EHE. The patient underwent external beam radiation to the left femoral head and neck. This was followed by fractionated radiosurgery to the left third metatarsal. Once the left foot wound had healed, the patient subsequently received four cycles of doxorubicin and ifosfamide. A restaging positron emission tomography CT carried out after completion of therapy showed no metabolic evidence of residual primary tumour or metastasis. More than 2 years after completing his trimodality therapy, the patient remains fully functional and symptom free. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26184358      PMCID: PMC4513580          DOI: 10.1136/bcr-2015-210196

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

Review 1.  Epithelioid hemangioendothelioma of the spine: results at seven years of average follow-up in a series of 10 cases surgically treated and a review of literature.

Authors:  Alessandro Luzzati; Fabio Gagliano; Giuseppe Perrucchini; Gennaro Scotto; Carmine Zoccali
Journal:  Eur Spine J       Date:  2014-08-15       Impact factor: 3.134

2.  Multifocal epithelioid hemangioendothelioma of the lower limbs detected by 18F-FDG PET/MRI.

Authors:  Giorgio Treglia; Luca Ceriani; Gaetano Paone; Tiziana Rusca; Massimo Bongiovanni; Luca Giovanella
Journal:  Clin Nucl Med       Date:  2014-09       Impact factor: 7.794

3.  Hemangioma, hemangiopericytoma, and hemangioendothelioma (angiosarcoma) of bone.

Authors:  K K Unni; J C Ivins; J W Beabout; D C Dahlin
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

4.  Treatment of epithelioid hemangioendothelioma of bone using a novel combined approach.

Authors:  D I Rosenthal; M E Treat; H J Mankin; A E Rosenberg; C L Jennings
Journal:  Skeletal Radiol       Date:  2001-04       Impact factor: 2.199

5.  Primary vascular tumors of bone: a spectrum of entities?

Authors:  Sofie L J Verbeke; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2011-07-25

6.  Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

Authors:  Christine Chevreau; Axel Le Cesne; Isabelle Ray-Coquard; Antoine Italiano; Angela Cioffi; Nicolas Isambert; Yves Marie Robin; Charles Fournier; Stéphanie Clisant; Loic Chaigneau; Jacques-Olivier Bay; Emmanuelle Bompas; Eric Gauthier; Jean Y Blay; Nicolas Penel
Journal:  Cancer       Date:  2013-04-15       Impact factor: 6.860

7.  Radiotherapy as an effective primary treatment for epithelioid haemangioendothelioma of the cervical spine.

Authors:  Kein-Leong Yim; Vaiyapuri P Sumathi; David Spooner
Journal:  Anticancer Res       Date:  2012-10       Impact factor: 2.480

8.  Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone.

Authors:  Andrea Angelini; Andreas F Mavrogenis; Marco Gambarotti; Biagio Merlino; Piero Picci; Pietro Ruggieri
Journal:  J Surg Oncol       Date:  2014-03-18       Impact factor: 3.454

9.  Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma.

Authors:  Olivia Bally; Louis Tassy; Bertrand Richioud; Anne-Valérie Decouvelaere; Jean-Yves Blay; Olfa Derbel
Journal:  Clin Sarcoma Res       Date:  2015-04-23

10.  A multidisciplinary approach to the management of atypical osseous epithelioid hemangioendothelioma.

Authors:  J K Ma; J Barr; S Vijayakumar
Journal:  Case Rep Oncol Med       Date:  2014-02-18
View more
  1 in total

Review 1.  Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.

Authors:  Ari Rosenberg; Mark Agulnik
Journal:  Curr Treat Options Oncol       Date:  2018-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.